| HOME >> MEDICINE >> TECHNOLOGY |
The Principle Investigator of the trial is Dr. Charles Shapiro, Director of Breast Oncology at Ohio State University.
The trial will be open at the following clinical sites under the
directorship of the listed investigators:
Institution Site Principle Investigator
Breastlink Medical Group, Long Beach,
California Dr. Bichlien Nguyen
California Cancer Care Inc.,
Greenbrae/San Mateo, California Dr. Peter Eisenberg
Columbia Presbyterian Medical Center,
New York, New York Dr. Dawn Hershman
Comprehensive Cancer Center at Desert
Regional Medical Center, Palm Springs,
California Dr. Gail Leichman
Duke University, Durham, North Carolina Dr. Gretchen Kimmick
Lynn Regional Cancer Center, Boca Raton,
Florida Dr. Reshma Mahtani
MD Anderson, Houston, Texas Dr. Banu Arun
Memorial Cancer Institute, Hollywood,
Florida Dr. Alejandra Perez
Montefiore Medical Center, Bronx,
New York Dr. Tianhong Li
Ohio State University, Columbus, Ohio Dr. Ewa Mrozek
St. Vincent's Medical Center, New York,
New York Dr. Paula Klein
University of California, San Francisco Dr. Hope Rugo
University of Chicago, Chicago, Illinois Dr. Gini Fleming
University of Miami, Miami, Florida Dr. Alberto Montero
University of Pittsburg Magee Women's
Hospital, Pittsburg, Pennsylvania Dr. Adam Brufsky
University of Southern California,
Los Angeles, California Dr. Agustin Garcia
Univ
'/>"/>
| SOURCE Bionovo, Inc. Copyright©2008 PR Newswire. All rights reserved |